Discover 2,017 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,017
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
for
Somatostatin Receptor Positive (SSTR+),
Location: Hartford CT, New Haven CT, New York NY, Montreal,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06784752
Phase 3, Recruiting
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
for
Lymphoma, Lymphoma, Non Hodgkin
Location: New York NY, Philadelphia PA, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07082803
Phase 1, Recruiting
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
for
Cancer, Cancer Survivors, Gastrointestinal Cancers,
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute
Sex: All
Age: 18+
Code: NCT06908629
Recruiting
First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy
for
Non Small Cell Lung Cancer
Location: Detroit MI
Sponsor: Nerissa T. Viola
Sex: All
Age: 18+
Code: NCT06439914
Phase 1, Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
for
Malignant Neoplasm
Location: Boston MA, New Haven CT, Valhalla NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT06941272
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for
Moderate Aortic Valve Stenosis
Location: Boston MA, Quebec, The Bronx NY, Albany NY, Montreal,
Sponsor: Kardigan, Inc.
Sex: All
Age: 50+
Code: NCT07001800
Phase 2, Phase 3, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Boston MA, Wilson NC, Chapel Hill NC, Pembroke Pines FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05714839
Phase 1, Phase 2, Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
for
Vitiligo, Non-Segmental Vitiligo (NSV)
Location: Portsmouth NH, Boston MA, Chicoutimi, The Bronx NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07533019
Phase 2, Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Halifax, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase 3, Recruiting
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
for
Clostridioides Difficile Infection
Location: Halifax, Boston MA, Hamden CT, Quebec, Sherbrooke,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07285213
Phase 2, Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
for
Primary Membranous Nephropathy
Location: The Bronx NY, Greenville NC, London, Cleveland OH,
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT06962800
Phase 3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Worcester MA, Pittsburgh PA, Sarasota FL, Detroit MI,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06682988
Phase 2, Recruiting
FITting Non-invasive Tests in Lynch Syndrome Surveillance
for
Colorectal Cancer
Location: New York NY, Ann Arbor MI, Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 20 - 70+
Code: NCT06898996
Recruiting
UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF
for
Heart Failure, Polygenic Score
Location: Detroit MI
Sponsor: David Lanfear
Sex: All
Age: 18 - 70+
Code: NCT07054489
Recruiting
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
for
Breast Cancer, Metastatic
Location: New York NY, Washington D.C. DC, Fairfax VA, Durham NC,
Sponsor: ALX Oncology Inc.
Sex: All
Age: 18+
Code: NCT07007559
Phase 2, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St. John's, Bangor ME, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease